Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6 thioguanine (NSC-752)

J. O. Armitage, C. P. Burns

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Twenty adults (median age, 58 yr) with acute nonlymphoblastic leukemia who had achieved complete remission were given maintenance therapy with monthly courses of cytosine arabinoside and 6 thioguanine, each in a dose of 100 mg/m2 every 12 hr for 10 doses. The toxicity was minimal with no severe infections, bleeding, or treatment related deaths. The treatment was often administered on an outpatient basis. The predicted life table median remission duration is 14 mth with 11 patients still in remission from 3+ to 29+ mth.

Original languageEnglish (US)
Pages (from-to)585-589
Number of pages5
JournalCANCER TREAT.REP.
Volume60
Issue number5
StatePublished - 1976
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6 thioguanine (NSC-752)'. Together they form a unique fingerprint.

Cite this